Anixa Biosciences Stock Today
| ANIX Stock | USD 3.00 0.13 4.53% |
Performance0 of 100
| Odds Of DistressLess than 42
|
Anixa Biosciences is trading at 3.00 as of the 12th of May 2024; that is 4.53 percent up since the beginning of the trading day. The stock's open price was 2.87. Anixa Biosciences has about a 42 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Anixa Biosciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 12th of February 2024 and ending today, the 12th of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of January 1987 | Category Healthcare | Classification Health Care |
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California. Anixa Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 31.9 M outstanding shares of which 632.1 K shares are presently shorted by private and institutional investors with about 6.01 trading days to cover. More on Anixa Biosciences
Moving together with Anixa Stock
| 0.7 | EVOK | Evoke Pharma | PairCorr |
Moving against Anixa Stock
| 0.83 | JANX | Janux Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.61 | VRCA | Verrica Pharmaceuticals Earnings Call Tomorrow | PairCorr |
| 0.55 | YCBD | cbdMD Inc Earnings Call Tomorrow | PairCorr |
| 0.51 | ELYM | Eliem Therapeutics Earnings Call Tomorrow | PairCorr |
| 0.43 | HCWB | HCW Biologics | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 12th of June 2024
Anixa Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Anixa Biosciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Anixa Biosciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Amit Kumar | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Anixa Biosciences report their recommendations after researching Anixa Biosciences' financial statements, talking to executives and customers, or listening in on Anixa Biosciences' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Anixa Biosciences. The Anixa consensus assessment is calculated by taking the average forecast from all of the analysts covering Anixa Biosciences. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Anixa Biosciences' liquidity, profitability, solvency, and operating efficiency, Anixa Biosciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in June. Financial strength of Anixa Biosciences is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anixa Biosciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Anixa Biosciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Anixa Biosciences' financial leverage. It provides some insight into what part of Anixa Biosciences' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anixa Biosciences (ANIX) is traded on NASDAQ Exchange in USA. It is located in 3150 Almaden Expressway, San Jose, CA, United States, 95118 and employs 4 people. Anixa Biosciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 95.7 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anixa Biosciences's market, we take the total number of its shares issued and multiply it by Anixa Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Anixa Biosciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 31.9 M outstanding shares of which 632.1 K shares are presently shorted by private and institutional investors with about 6.01 trading days to cover.
Anixa Biosciences currently holds about 31.66 M in cash with (6.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03.
Check Anixa Biosciences Probability Of Bankruptcy
Ownership AllocationAnixa Biosciences retains a total of 31.9 Million outstanding shares. Anixa Biosciences shows 4.9 percent of its outstanding shares held by insiders and 14.635 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Anixa Ownership Details
Anixa Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Anixa Biosciences jumping above the current price in 90 days from now is about 82.95%. The Anixa Biosciences probability density function shows the probability of Anixa Biosciences stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Anixa Biosciences has a beta of 0.5511. This suggests as returns on the market go up, Anixa Biosciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Anixa Biosciences will be expected to be much smaller as well. Additionally, anixa Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Anixa Biosciences to move above the current price in 90 days from now is about 82.95 (This Anixa Biosciences probability density function shows the probability of Anixa Stock to fall within a particular range of prices over 90 days) .
Anixa Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Anixa Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Anixa Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Anixa Biosciences' value.| Instituion | Recorded On | Shares | |
| Northern Trust Corp | 2023-12-31 | 51.5 K | |
| Qube Research & Technologies | 2023-12-31 | 48.5 K | |
| Jane Street Group, Llc | 2023-12-31 | 43.4 K | |
| Cambridge Invest Research Advisors, Inc. | 2023-12-31 | 40 K | |
| Ci Private Wealth Llc | 2023-12-31 | 37.4 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 36.5 K | |
| Gemmer Asset Management Llc | 2023-12-31 | 35 K | |
| Lpl Financial Corp | 2023-12-31 | 28.1 K | |
| Dimensional Fund Advisors, Inc. | 2023-12-31 | 21.2 K | |
| Vanguard Group Inc | 2023-12-31 | 1.4 M | |
| Ubs Group Ag | 2023-12-31 | 580.6 K |
Anixa Biosciences Historical Income Statement
Anixa Biosciences Income Statement is one of the three primary financial statements used for reporting Anixa's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Anixa Biosciences revenue and expense. Anixa Biosciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Anixa Biosciences' Interest Expense is fairly stable compared to the past year. Total Other Income Expense Net is likely to rise to about 1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.2 M in 2024. View More FundamentalsAnixa Stock Against Markets
Picking the right benchmark for Anixa Biosciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Anixa Biosciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Anixa Biosciences is critical whether you are bullish or bearish towards Anixa Biosciences at a given time. Please also check how Anixa Biosciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Anixa Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
How to buy Anixa Stock?
Before investing in Anixa Biosciences, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Anixa Biosciences. To buy Anixa Biosciences stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Anixa Biosciences. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Anixa Biosciences stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Anixa Biosciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Anixa Biosciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Anixa Biosciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.
Already Invested in Anixa Biosciences?
The danger of trading Anixa Biosciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Anixa Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Anixa Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Anixa Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Anixa Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Anixa Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anixa Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anixa Biosciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anixa Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Anixa Stock analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Anixa Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anixa Biosciences. If investors know Anixa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anixa Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.34) | Revenue Per Share 0.007 | Return On Assets (0.28) | Return On Equity (0.43) |
The market value of Anixa Biosciences is measured differently than its book value, which is the value of Anixa that is recorded on the company's balance sheet. Investors also form their own opinion of Anixa Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Anixa Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anixa Biosciences' market value can be influenced by many factors that don't directly affect Anixa Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anixa Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anixa Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anixa Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.